The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study
- PMID: 15797654
- DOI: 10.1016/j.amjhyper.2004.09.019
The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study
Abstract
Background: Thiazide diuretics and angiotensin-converting enzyme inhibitors can cause excessive urinary zinc (Zn) loss and Zn depletion. Thiazides may also induce magnesium (Mg) deficiency, which may exacerbate hypertension. Data on the effects of angiotensin receptor blockers on Zn and Mg homeostasis are scarce.
Methods: Seventeen hypertensive patients were studied (ten men and seven women, age 50 +/- 3 years, blood pressure 158 +/- 5 / 95 +/- 3 mm Hg). Patients were treated with losartan 50 mg/day for 4 weeks followed by a fixed combination of 50 mg losartan and 12.5 mg hydrochlorothiazide for 4 weeks more. Blood and 24-h urine were collected at baseline and after each study period. Zinc and Mg levels were measured in serum, urine, and peripheral blood mononuclear cells. Nitric oxide metabolites were measured in urine.
Results: Treatment with losartan resulted in a significant increase in the urinary Zn/creatinine ratio (from 0.020 +/- 0.004 microg/mg to 0.034 +/- 0.005 microg/mg, P = .02), which was further increased by the losartan/hydrochlorothiazide combination (from 0.034 +/- 0.005 microg/mg to 0.053 +/- 0.008 microg/mg, P = .03). Serum Zn levels were significantly decreased after losartan/hydrochlorothiazide (from 80.0 +/- 4.0 microg/dL at baseline to 74.0 +/- 3.0 microg/dL, P = .007). Peripheral blood mononuclear Zn concentrations were decreased also, but this was not statistically significant. Serum, urinary, and peripheral blood mononuclear Mg levels were not significantly affected by treatment. Nitric oxide urinary metabolites were unchanged throughout the study.
Conclusions: Treatment with losartan causes an increase in urinary Zn excretion and induces Zn deficiency in patients with hypertension. The addition of hydrochlorothiazide has an additive effect. Magnesium and nitric oxide metabolism are not affected by either treatment.
Comment in
-
Angiotensin receptor blockers and magnesium status in essential hypertension.Am J Hypertens. 2005 Dec;18(12 Pt 1):1636; author reply 1637. doi: 10.1016/j.amjhyper.2005.05.010. Am J Hypertens. 2005. PMID: 16364839 No abstract available.
Similar articles
-
Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.Pharmacotherapy. 2009 Sep;29(9):1061-72. doi: 10.1592/phco.29.9.1061. Pharmacotherapy. 2009. PMID: 19698011 Clinical Trial.
-
Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.Clin Exp Hypertens. 2011;33(8):565-70. doi: 10.3109/10641963.2011.577487. Epub 2011 Sep 29. Clin Exp Hypertens. 2011. PMID: 21958001
-
Effect of losartan plus hydrochlorothiazide on nitric oxide status in 'nondipper' hypertensive patients.Am J Ther. 2007 Mar-Apr;14(2):161-5. doi: 10.1097/01.pap.0000249921.68387.40. Am J Ther. 2007. PMID: 17414584 Clinical Trial.
-
Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1285-303. doi: 10.1517/17425250903282799. Expert Opin Drug Metab Toxicol. 2009. PMID: 19761411 Review.
-
[Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours].MMW Fortschr Med. 2007 Sep 6;149(35-36):38. MMW Fortschr Med. 2007. PMID: 17944283 Review. German. No abstract available.
Cited by
-
Sex-dependent, zinc-induced dephosphorylation of phospholamban by tissue-nonspecific alkaline phosphatase in the cardiac sarcomere.Am J Physiol Heart Circ Physiol. 2014 Sep 15;307(6):H933-8. doi: 10.1152/ajpheart.00374.2014. Epub 2014 Jul 11. Am J Physiol Heart Circ Physiol. 2014. PMID: 25015959 Free PMC article.
-
Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failure.Clin Res Cardiol. 2014 Nov;103(11):938-49. doi: 10.1007/s00392-014-0735-x. Epub 2014 Jun 8. Clin Res Cardiol. 2014. PMID: 24908339
-
Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent.Biometals. 2024 Aug;37(4):983-1022. doi: 10.1007/s10534-024-00590-5. Epub 2024 Apr 5. Biometals. 2024. PMID: 38578560 Free PMC article.
-
Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.J Cardiovasc Pharmacol. 2008 Sep;52(3):245-52. doi: 10.1097/FJC.0b013e3181833eb8. J Cardiovasc Pharmacol. 2008. PMID: 18806605 Free PMC article.
-
Macro- and micronutrients in African-Americans with heart failure.Heart Fail Rev. 2006 Mar;11(1):45-55. doi: 10.1007/s10741-006-9192-6. Heart Fail Rev. 2006. PMID: 16819577 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical